Excellence in evidence based scientific updates on HPV infection and related Cancers
EUROGIN Roadmaps are aimed at updating the highest standards in HPV related cancer by translating evidence-based data into clinical practice. The rapidly increasing volume and complexity of medical progress in the field makes it difficult for physicians to incorporate data into daily practice. EUROGIN Roadmaps are designed as a tool to assist physicians in the decision making process, and hence improve quality of care. The process of developing guidelines includes needs' assessment, defining and evaluating implementation options. Revision is complex and requires a great deal of expertise and experience. This collection of peer reviewed papers provided by a broad group of international and independent experts is an exciting piece of work of the scientific evidence in this field.
Eurogin 2016 Roadmap: how HPV knowledge is changing
Nicolas Wentzensen1, Marc Arbyn2, Johannes Berkhof3, Mark Bower4, Karen Canfell5, Mark Einstein6, Christopher Farley7,
Joseph Monsonego8 and Silvia Franceschi9
(Int. J. Cancer: 140, 2192–2200 (2017) VC 2016 UICC)
Eurogin Roadmap 2015: How has HPV knowledge changed
our practice: Vaccines
Brotherton JM1,2, Jit M3,4, Gravitt PE5, Brisson M6, Kreimer AR7, Pai SI8, Fakhry C9, Monsonego J10, Franceschi S11
(Int J Cancer. 2016 Aug 1;139(3):510-7)
Educational platform on Human Papillomavirus associated Cancers
EUROGIN is a platform on education, training, scientific research, expertise and networking on Human Papillomavirus and associated cancers in both genital and non-genital sites.
Started in 1993 as a conference where scientific progress and clinical practice converge, EUROGIN shares translational research with an international scientific community, aiming at accelerating the reduction of the burden of HPV related cancers and their mortality.